Instructions to Authors

The European Journal of Breast Health (Eur J Breast Health) is an international, open access, online-only periodical published in accordance with the principles of independent, unbiased, and double-blinded peer-review.

The journal is owned by Turkish Federation of Breast Diseases Societies and affiliated and it is published quarterly on January, April, July, and October. The publication language of the journal is English.

The target audience of the journal includes specialists and medical professionals in general surgery and breast diseases.

The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal conforms with the Principles of Transparency and Best Practice in Scholarly Publishing (

Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or published in any electronic or printed medium. The journal should be informed of manuscripts that have been submitted to another journal for evaluation and rejected for publication. The submission of previous reviewer reports will expedite the evaluation process. Manuscripts presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.

Manuscripts submitted to the European Journal of Breast Health will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in their fields in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions.

World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects,” amended in October 2013, is required for experimental, clinical, and drug studies and some case reports. If required, Ethics Committee Reports or an equivalent official document will be requested from the authors. For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures they may undergo. For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly. Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the “Materials and Methods” section of the manuscript. It is the authors’ responsibility to protect the patients’ anonymity carefully. For photographs that may reveal the identity of the patients, signed releases of the patient or their legal representative should be enclosed.

All submissions are screened by a similarity detection software (iThenticate by CrossCheck).

In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE guidelines.

Each individual listed as an author should fulfill the authorship criteria recommended by the International Committee of Medical Journal Editors.

The ICMJE recommends that authorship be based on the following 4 criteria:

1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and

2. Drafting the work or revising it critically for important intellectual content; and

3. Final approval of the version to be published; and

4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work he/she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged in the title page of the manuscript.

The European Journal of Breast Health requires corresponding authors to submit a signed and scanned version of the Copyright Transfer and Acknowledgement of Authorship Form during the initial submission process in order to act appropriately on authorship rights and to prevent ghost or honorary authorship. If the editorial board suspects a case of “gift authorship,” the submission will be rejected without further review. As part of the submission of the manuscript, the corresponding author should also send a short statement declaring that he/she accepts to undertake all the responsibility for authorship during the submission and review stages of the manuscript.

European Journal of Breast Health requires and encourages the authors and the individuals involved in the evaluation process of submitted manuscripts to disclose any existing or potential conflicts of interests, including financial, consultant, and institutional, that might lead to potential bias or a conflict of interest. Any financial grants or other support received for a submitted study from individuals or institutions should be disclosed to the Editorial Board. To disclose a potential conflict of interest, the ICMJE Potential Conflict of Interest Disclosure Form should be filled in and submitted by all contributing authors. Cases of a potential conflict of interest of the editors, authors, or reviewers are resolved by the journal’s Editorial Board within the scope of COPE and ICMJE guidelines.

The Editorial Board of the journal handles all appeal and complaint cases within the scope of COPE guidelines. In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process for all appeals and complaints.


European Journal of Breast Health is an open access publication, and the journal’s publication model is based on Budapest Open Access Initiative (BOAI) declaration. All published content is available online, free of charge at The journal’s content is licensed under a Creative Commons Attribution-NonCommercial (CC BY-NC-ND) 4.0 International License which allows third parties to share the material for copying and redistributing it in any medium or format under the terms of giving the appropriate credit to the original work, using only for non-commercial purposes and not distributing the modified version if you remixed, transform or build upon the material.

The authors agree to transfer the copyright to the Turkish Federation of Breast Diseases Societies. if the article is accepted for publication. The European Journal of Breast Health requires corresponding authors to submit a signed and scanned version of the Copyright Transfer and Acknowledgement of Authorship Form during the initial submission process.

Submission Fee

As of January 1, 2021, "European Journal of Breast Health" charges a submission fee of $50 for all "original articles, case reports and reviews" submitted manuscripts from the authors during the first submission.

You can make your payments via two options of credit card (3D secure) and remittance methods. You can visit our website to find more about purchasing (

**If you make your payment via remittance, please send your purchase receipt to the email address "[email protected]" and upload it while submitting your manuscript.
**If you make your payment via 3D secure Vpos method, the payment link for your submission will be sent to your email address for you to purchase.
**Authors do not need to make a payment for the resubmissions.
**Please note that the submission fee purchase affects neither the evaluation process of the manuscript nor priority.
**The article types of editorial comment, image in clinical practice, current opinion and letter to the editor are free of charge..

The services provided in this context are the provision of systems for editors and authors, editorial work, provision of article designs, the establishment of indexing links, provision of other publishing services and support services.

You can take a look at the unbiased article evaluation process here. If you find a problem with the open access status of your article or licensing, you can contact [email protected]

After your submission to the Eur J Breast Health evaluation system, the submission fees are collected from you or through your fund provider, institution or sponsor.

Eur J Breast Health regularly reviews the fees of submission fees and may change the fees for submission fees. When determining the costs for Eur J Breast Health submission fees, it decides according to the following developments.

• Quality of the journal,
• Editorial and technical processes of the journal,
Market conditions,
 Other revenue streams associated with the journal

You can find the submission fees fee list here.

When and How do I pay?

After the article is submitted to the Eur J Breast Health online evaluation system, an email regarding payment instructions will be sent to the corresponding author.

The editorial review process will be initiated after the payment has been made for the article.

There are two options to purchase the submission fee:

1- Making a remittance

The payment is needed to be made to the account number below. While purchasing the submission fee, please indicate your article manuscript title in the payment description section.

Account no/IBAN: TR49 0011 1000 0000 0098 1779 82 (TL)

                                TR17 0011 1000 0000 0098 5125 29 (USD)

                                TR73 0011 1000 0000 0098 5125 88 (EUR)

Account name: Meme Hastalıkları Dernekleri Federasyonu İktisadi İşletmesi

Branch code (QNB Finans Bank Cerrahpaşa): 1020


NOTE: All authors must pay the bank wire fee additionally. Otherwise, the deducted amount of the submission fee is requested from the author.

2- Virtual POS method (Credit card payment with 3D Secure)

The payment link will be sent to you for your purchase. You can contact us if you have further questions in this regard.

If you believe payment instructions are not in your email contact us via the email addresses [email protected] and [email protected]

Refund policy:

The Eur J Breast Health will refund the overpayments of the submission fees for the same article or in case of multiple payments by the authors and financiers as free submission fees payment code to be used in the submission fees system.

Withdrawal of the article; There is no refund for articles whose editorial review has started in the Eur J Breast Health system. You can view article retraction policies here.

Returning the article to the author; The European Journal of Breast Health will refund the submission fees with a coupon code if the article is returned to the author. Using this code, authors can use the submission fees of different articles without making a new payment. You can view article return policies here.

Rejecting or accepting the article; Eur J Breast Health does not refund any submission fees for articles whose editorial process has started, and the process has been completed.

Preprint policy

By definition, a "preprint" is an early version of an article before the version is accepted for publication in a journal.

According to European Journal of Breast Health’s editorial guidelines, articles submitted to the journals should not be published elsewhere before, or under evaluation for publication in similar journals or sources. However, deposition of a manuscript in a preprint archive shall not be viewed as prior publication.

Upon acceptance of an article for publication the author must be able to agree to the terms of the relevant journal’s License to Publish or Copyright Assignment form. After the article is published, the preprint can still be shared and used under its original license terms.

It is best practice to link preprints and the published article (the ‘Version of Record’). If appropriate, authors are encouraged to include details of preprint submissions, including DOI or other permanent identifiers, when submitting text to a journal. Authors are also encouraged to ensure that the preprint record is later updated with a DOI and a URL link to the published version of the article if their article is accepted.